Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05400174 · ClinicalTrials.gov registry record · NA

Blood Pressure Effects on Cognition and Brain Blood Flow in PD

A NA study of Parkinson Disease and Orthostatic Hypotension, sponsored by University of California, San Diego.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05400174: Recruiting NA study of Parkinson Disease and Orthostatic Hypotension, sponsored by University of California, San Diego.

NCT05400174 is a NA study of Parkinson Disease and Orthostatic Hypotension that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 60 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05400174, a NA study of Parkinson Disease and Orthostatic Hypotension, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Parkinson's disease (PD) is the second most common neurodegenerative disorder worldwide. Besides causing symptoms that impair movement, PD also causes non-motor symptoms, such as problems thinking and orthostatic hypotension (OH), i.e., low blood pressure (BP) when standing. About one-third of people with PD have OH, which can cause sudden, temporary symptoms while upright, including lightheadedness, dizziness, and fainting. People with PD and OH can also experience problems thinking that happen only while upright and not while sitting - this can occur without other symptoms, such as feeling dizzy or faint. However, the level of low BP that can affect thinking remains unknown, and no guidelines exist for treating OH when it happens without symptoms. This is significant because OH could be a treatable risk factor for thinking problems in PD, but OH is often not treated if people do not report obvious symptoms. This project's goal is to determine how BP affects brain function in PD. The proposed experiments will measure BP and brain blood flow continuously in real-time using innovative wearable technology. Persons with PD with OH and without OH will undergo repeated cognitive tests while supine (lying down) and while upright. I will study the associations between BP, thinking abilities, and brain blood flow, and will compare groups with and without OH. These findings could be important because if a certain level of BP correlates with thinking abilities, then treating OH in PD may prevent thinking problems, which would improve health-related quality of life and reduce disability and healthcare costs.

Primary Outcome

Participant says as many words in 1 minute as possible each of several letter or category prompts.

Interventions

  • DIAGNOSTIC_TEST Tilt table (upright position)

Study Locations (1)

California

  • University of California San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-12-14
Est. Completion 2026-02-01
Phase NA
University of California, San Diego

775 total trials

What NCT05400174 shows while recruiting

NCT05400174 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Tilt table (upright position) is the first listed.

NCT05400174 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05400174 about?

NCT05400174 is a clinical study titled "Blood Pressure Effects on Cognition and Brain Blood Flow in PD". Parkinson's disease (PD) is the second most common neurodegenerative disorder worldwide. Besides causing symptoms that impair movement, PD also causes non-motor symptoms, such as problems thinking and orthostatic hypotension (OH), i.e., low blood pressure (BP) when standing. About one-third of peopl...

What is the current status of trial NCT05400174?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-12-14. Estimated completion is 2026-02-01.

What conditions does trial NCT05400174 study?

This clinical trial studies the following conditions: Parkinson Disease, Orthostatic Hypotension, Dysautonomia.

What interventions are being tested in trial NCT05400174?

The interventions under investigation include: Tilt table (upright position) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05400174?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05400174 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05400174's enrollment target sits among peer trials

60 125th of 297 higher than 154 of 297 other Parkinson Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

  • NCT02114450 · 60 participants · NA

    Human-Machine System for the H2 Lower Limb Exoskeleton

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05400174, the US trial registry maintained by the National Library of Medicine. NCT05400174 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.